Prevalence and clinical characteristics of X-linked hypophosphatemia in Paraná, southern Brazil
Authors:
- Carolina Aguiar MoreiraCMCarolina Aguiar Moreira
- Tatiana M. R. Lemos CostaTCTatiana M. R. Lemos Costa
- Julia Vieira Oberger MarquesJMJulia Vieira Oberger Marques
- Lucimary SylvestreLSLucimary Sylvestre
- Ana Cristina R. AlmeidaAAAna Cristina R. Almeida
- Eliane M. C. P. MalufEMEliane M. C. P. Maluf
- Victória Z. C. BorbaVBVictória Z. C. Borba
Open Access
- 9 October 2020
- journal article
- research article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 64 (AHEAD) , 796-802
Abstract
Objective: The aim of this cross-sectional study was to estimate the prevalence of XLH in Parana, a state in southern Brazil, and report the clinical features and complications of the disease. Materials and methods: We invited all endocrinologists (n = 205), nephrologists (n = 221), orthopedic surgeons (n = 1020), and pediatricians (n = 1000) in Parana to fill out an electronic survey with information on patients with X-linked hypophosphatemia (XLH), and searched the records of the state's health department for all calcitriol prescriptions in 2018. Results: In all, 244 (10%) specialists responded to the email, of whom 18 (7.4%) reported to be taking care of patients with XLH and answered the online survey. A total of 57 patients with XLH were identified (prevalence 5 per million inhabitants). The median age at diagnosis was 22 years, and 42.2% were children and adolescents. Fifteen patients had genetic testing showing a PHEX mutation. Overall, 91.2% had bone deformities, 30.8% had a history of fragility fractures, and 22.4% had renal complications. Conclusion: This study demonstrated a prevalence of XLH of 5 cases per million inhabitants in the state of Parana, a rate lower than the one reported in other countries. Manifestations of renal calcification and bone fragility were frequent among the patients. This is the first epidemiological study evaluating the prevalence and clinical presentation of XLH in Latin America.Keywords
This publication has 24 references indexed in Scilit:
- Abnormalities in Muscle Density and Muscle Function in Hypophosphatemic RicketsThe Journal of Clinical Endocrinology & Metabolism, 2012
- A clinician's guide to X-linked hypophosphatemiaJournal of Bone and Mineral Research, 2011
- Phosphaturia as a Promising Predictor of Recurrent Stone Formation in Patients with UrolithiasisKorean Journal of Urology, 2010
- Nutritional rickets in Denmark: a retrospective review of children’s medical records from 1985 to 2005European Journal of Pediatrics, 2008
- Hypophosphatemic rickets: results of a long-term follow-upPediatric Nephrology, 2005
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolismJournal of Clinical Investigation, 2004
- PHEX gene and hypophosphatemiaKidney International, 2000
- Effects of Therapy in X-Linked Hypophosphatemic RicketsNew England Journal of Medicine, 1991
- X-Linked HypophosphatemiaMedicine, 1989